PEComas are immunoreactive for both smooth muscle (desmin, SMA, muscle-specific-actin, muscle myosin, and calponin) and melanocytic (HMB-45, Melan-A/MART-1, tyrosinase, and MITF) markers (10). The gene discussed is MLANA; the disease is neoplasm with perivascular epithelioid cell differentiation.